TWINRIX
TWINRIX is a pharmaceutical drug with 12 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.0%
9 of 10 finished
10.0%
1 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination
Clinical Trials (12)
Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612
Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths
Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults
Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder
Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12